Priyanka Kanth

Priyanka Kanth, MD, is a gastroenterologist at MedStar Georgetown University Hospital. A fellowship-trained and board-certified gastroenterologist, she leads the Gastrointestinal Cancer Prevention Program for patients and families at high risk of developing gastrointestinal cancer. Her expertise includes gastrointestinal cancer, especially hereditary colon cancer, and colon cancer prevention.

Dr. Kanth's research interests include colon polyps, serrated colon polyps, and hereditary gastrointestinal cancer syndromes, which include Lynch syndrome, familial adenomatous polyposis, juvenile polyposis syndrome, Peutz-Jeghers syndrome, serrated polyposis syndrome, hamartomatous polyposis syndromes, hereditary diffuse gastric cancer, gastrointestinal cancer genetics, and colon cancer prevention.

She has been the principal investigator and site principal investigator of several studies on gastrointestinal cancer. Her research studies have been published in peer-reviewed journals, including the New England Journal of Medicine, the New England Journal of Medicine, the American Journal of Clinical Nutrition, and the Journal of the National Comprehensive Cancer Network. Additionally, she has presented at several national and international conferences.

Dr. Kanth graduated from medical school and completed her internship at Kasturba Medical College, Mangalore, MAHE University, India. She completed a residency in internal medicine at the University Of Connecticut Health, Farmington, CT, where she served as Chief Medical Resident, followed by a residency in colorectal and general surgery at Royal Albert Edward Infirmary in the United Kingdom and a fellowship in gastroenterology at the University of Utah Health.

Research interests

Area of special interest and expertise is in colon polyps, hereditary gastrointestinal gastrointestinal conditions, and colon cancer prevention.

Selected research

1. This is a global practice survey on chemopreventive approached in hereditary gastrointestinal syndrome (Lynch syndrome and FAP).
   Publication: PMID: 37293588
   Kate Mraz, Rachel Hodan, Linda Rodgers-Fouche, Sanjeevani Arora, Francesc Balaguer, Jose Guillem, Joanne Jeter, Priyanka Kanth, Dan Li, David Liska, Joshua Melson, Kimberly Perez, Charite Ricker, Brian Shirts, Eduardo Vilar, Bryson Katona and Mev Dominguez-Valentin (2023). Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: A global clinical practice survey. Frontiers in Oncology. May
2. This is a study to evlaute cancer risk in patient with serrated polyposis syndrome and sporadic sessile serrated lesions.
   Publication : PMID: 34889311
   Kanth P, Yu Z, Keener MB, Koptiuch C, Kohlmann WK, Neklason DW, Westover M, Curtin K (2022). Cancer Risk in Patients With and Relatives of Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions. Am J Gastroenterol. Feb 1;117(2):336-342.
3. Invited review on screening and prevention of colorectal cancer
   Kanth P, Inadomi JM (2021). Screening and prevention of colorectal cancer. BMJ, 374, n1855.
4. This is randomized trial of chemopreventive agent in Familail adenomatous polyposis.
   Publication: PMID 32905675
   Burke CA, Dekker E, Lynch P, Samadder NJ, Balaguer F, Hüneburg R, Burn J, Castells A, Gallinger S, Lim R, Stoffel EM, Gupta S, Henderson A, Kallenberg FG, Kanth P Roos VH, Ginsberg GG, Sinicrope FA, Strassburg CP, Van Cutsem E, Church J, Lalloo F, Willingham FF, Wise PE, Grady WM, Ford M, Weiss JM, Gryfe R, Rustgi AK, Syngal S, Cohen A. (2020). Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis. N Engl J Med. Sep 10;383(11):1028-1039.

Other information

Member and Fellow of

1. American College of Gastroenterology
2. American Gastroenterological Association
3. Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC)